Archive for July, 2010

FDA OKs first stem cell trial on humans

The world’s first authorized test in people of a therapy derived from human embryonic stem cells has been cleared by the Food and Drug Administration. The clinical trial could offer the first glimpse of the …

Stem-cell therapy to begin on humans

NEW YORK: The US Food and Drug Administration (FDA) has given the all-clear to a clinical trial of embryonic stem cells as a treatment for spinal-cord injury.

FDA Approves Embryonic Stem Cell-Based Therapy For Patients With Acute Spinal Cord Injury

The US FDA (Food and Drug Administration) has lifted a clinical hold on Geron’s Investigational New Drug (IND) application – the Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may now go ahead. GRNOPC1 is the first ever clinical trial of a human embryonic stem cell based therapy in humans…

1st high school stem cell curriculum offered

California is home to some of the world’s most promising stem cell research, but to sustain the industry, the state will need an ever-increasing army of trained workers – from lab technicians to top-level researchers – and a healthy backbone of nonscientists… Stem cell – Research – Science and Technology – Biotechnology – High school

Geron approved to test embryonic stem cells

Geron Corp. said it has been cleared by regulators to proceed with the first human test of an embryonic stem cell therapy, designed for patients with spinal-cord injuries. The shares rose as much as 16 percent …

FDA: Stem cell trial can proceed

WASHINGTON, July 30 (UPI) — The Food and Drug Administration has given approval to proceed with the world’s first human clinical trial of a human embryonic stem cell-based therapy. Food and Drug Administration – Stem cell – Clinical trial – Biotechnology – Biology

Stem Cell Trial Wins Approval of F.D.A.

A trial could offer the first glimpse of a technology that may hold vast medical promise but also is embroiled in controversy.

FDA Lifts Hold on Geron Stem Cell Trial, Shares Leap

WASHINGTON – The FDA’s blessing Friday of the world’s first clinical trial of a human embryonic stem cell (hESC) therapy has not only launched what may be “the dawn of a new era” for medical treatment, but if successful, the therapies could alleviate much of the burdensome costs plaguing the nation’s health care system, insisted Geron Corp. CEO Thomas Okarma.

F.D.A. Clears Way for Embryonic Stem Cell Trial Using Patients

Using human embryonic stem cells, the trial will be tested in patients with new spinal cord injuries.

UCI stem-cell treatment is world’s first

A therapy for acute spinal cord injuries developed by a UC Irvine scientist will become the world’s first clinical trial of a treatment using human embryonic stem cells. Geron Corp. of Menlo Park announced Friday that the U.S. Food and Drug…